Skip to content

Nexalin Technology Advances Neurostimulation Research for Veterans

Nexalin Technology, Inc. celebrates the U.S. House Appropriations Committee’s inclusion of language that encourages research into non-invasive deep brain neurostimulation for veterans suffering from treatment-resistant traumatic brain injury (TBI). This initiative, which was advocated by Nexalin America, aims to promote additional research at the Department of Veterans Affairs and follows a significant vote in favor of the related appropriations bill. Nexalin’s DIFS™ technology is highlighted as a potential breakthrough in non-invasive treatments, distinguishing it from traditional methods.

U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury